Account wins from the 08/29/06 News Brief

Share this article:
Mc|K Healthcare, a pharmaceutical advertising, branding and marketing firm has been retained by Alliant Pharmaceuticals as the agency of record to launch Orapred ODT (prednisolone sodium phosphate orally disintegrating tablets), for the treatment of asthma in children. Orapred ODT, which Alliant will start to market in September, is the first orally disintegrating tablet steroid available in the US.
Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Business Briefs

Email Newsletters

More in Business Briefs

Study says statins not enough for diabetic hearts

Researchers using an experimental test have discovered that the 50% of surveyed diabetics may also have undetected heart muscle damage.

Sanofi wants greater MS role

The plan is to bring in-house products to the market as well as through acquisitions.

Mylan buys branded and generic Arixtra

The $225-million deal will give Mylan one of two generics for the deep vein thrombosis drug.